Showing results (751-760 of 896) with videos related to
Sort By:
Pageof 90
Circulation. Cardiovascular Genetics|October 5, 2017
Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action PotentialNathan R Tucker, Elena V Dolmatova, Honghuang Lin, et al.Nature Medicine|April 19, 2022
Development of a clinical polygenic risk score assay and reporting workflowLimin Hao, Peter Kraft, Gabriel F Berriz, et al.European Heart Journal|August 18, 2022
A polygenic risk score predicts atrial fibrillation in cardiovascular diseaseNicholas A Marston, Amanda C Garfinkel, Frederick K Kamanu, et al.Lancet (London, England)|September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Gholamreza Roshandel, Peggy Gao, et al.JACC. Cardiooncology|February 19, 2025
SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial EnergeticsDanielle Medina-Hernández, Laura Cádiz, Annalaura Mastrangelo, et al.Circulation Research|January 23, 2024
Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational StudyRaquel Toribio-Fernández, Catarina Tristão-Pereira, Juan Carlos Silla-Castro, et al.European Heart Journal|November 12, 2023
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmiasArt Schuermans, Caitlyn Vlasschaert, Victor Nauffal, et al.The Journal of Clinical Investigation|August 2, 2021
Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotypeLaura Lecce, Yang Xu, Bhargavi V'Gangula, et al.Journal of the American College of Cardiology|August 30, 2020
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19Girish N Nadkarni, Anuradha Lala, Emilia Bagiella, et al.Circulation. Genomic and Precision Medicine|January 12, 2021
Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic DiseaseNicholas A Marston, Giorgio E M Melloni, Yared Gurmu, et al.Pageof 90